US FDA recommends less frequent liver testing with pravastatin

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 1997年 / 650卷 / 1期
关键词：
Liver Disease; Liver Function Testing; World Wide; Pravastatin; Reductase Inhibitor;
D O I：
10.2165/00128415-199706500-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] Less frequent testing for sexually transmitted infections: do the benefits outweigh the risks for vulnerable populations?
    Filip, Iulia
    AIDS, 2025, 39 (03) : N7 - N8
  • [22] US FDA-compliant devices offer a less painful way to administer cosmetic injectables for clinicians
    不详
    EXPERT REVIEW OF MEDICAL DEVICES, 2011, 8 (05) : 539 - 539
  • [23] Direct-to-Consumer Genetic Testing The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing
    Gill, Jennifer
    Obley, Adam J.
    Prasad, Vinay
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (23): : 2377 - 2378
  • [24] Small (1.5 cm or less) liver metastases: US-guided biopsy
    Middleton, WD
    Hiskes, SK
    Teefey, SA
    Boucher, LD
    RADIOLOGY, 1997, 205 (03) : 729 - 732
  • [25] Removing the FDA's Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan
    Feldman, William B.
    Mahesri, Mufaddal
    Sarpatwari, Ameet
    Huybrechts, Krista F.
    Zhu, Yanmin
    Hwang, Catherine S.
    Lii, Joyce
    Lee, Su Been
    Sreedhara, Sushama Kattinakere
    Toyserkani, Gita A.
    Zhou, Esther H.
    Zendel, Laura
    Lacivita, Cynthia
    Manzo, Claudia
    Dal Pan, Gerald J.
    Kesselheim, Aaron S.
    Bykov, Katsiaryna
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [26] The US FDA's proposed rule on laboratory-developed tests: Impacts on clinical laboratory testing
    Smith, Leslie
    Carricaburu, Lisa A.
    Genzen, Jonathan R.
    PRACTICAL LABORATORY MEDICINE, 2024, 40
  • [27] IMMUNOTOXICITY TESTING APPLIED TO DIRECT FOOD AND COLOR ADDITIVES - US FDA REDBOOK-II GUIDELINES
    HINTON, DM
    HUMAN & EXPERIMENTAL TOXICOLOGY, 1995, 14 (01): : 143 - 145
  • [28] Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate
    Khabbazi, Alireza
    Kolahi, Sousan
    Dastgiri, Saeed
    Hajialiloo, Mehrzad
    Nazeri, Mahshid
    Nazeri, Leila
    Sheikholeslami Salmasi, Arefe
    Gader, Sevda
    Bak Mohammad Zadeh, Shagayegh
    Ghasemi, Aisan
    Poormohammad, Arezu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (06) : 646 - 652
  • [29] METFORMIN USE IS ASSOCIATED WITH LESS FREQUENT SEVERE LIVER INJURY UPON HOSPITAL ADMISSIN WITH COVID-19
    Kuntzen, Christian
    Satapathy, Sanjaya
    Bernstein, David
    GASTROENTEROLOGY, 2022, 162 (07) : S1247 - S1247
  • [30] Is Non-Alcoholic Fatty Liver Disease Less Frequent among Women with Prader-Willi Syndrome?
    Bedogni, Giorgio
    Grugni, Graziano
    Nobili, Valerio
    Agosti, Fiorenza
    Saezza, Antonella
    Sartorio, Alessandro
    OBESITY FACTS, 2014, 7 (01) : 71 - 76
12345